After the
Conversation
Provider profile

CoreAge Rx 4Play

A sponsored preparation to discuss with the clinician, including its ingredients, instructions and continuing arrangement.

After the Conversation Editorial Desk
October 6, 2026 · AI-assisted · Not medically reviewed

The preparation
Compounded liquid with four active ingredients
The advertised price
$114 for five bottles / 10 mL
Read the conditions
Advertised as a one-month pack with assessment and shipping included; optional automatic refills after the first purchase.

What should the formulation discussion cover?

CoreAge's public product description lists apomorphine 2 mg, sildenafil 40 mg, tadalafil 4 mg and vardenafil 7.5 mg per 2 mL of 4Play. Those figures identify the advertised formula, not a personal instruction to use that volume. Ask what the actual dispensing label and directions will say. [Product information]

The product page calls the preparation an oral suspension, while the offer uses sublingual-solution language. Have the prescriber or pharmacist clarify the preparation and route instead of choosing between descriptions yourself. Bring the full list of other medicines to that conversation.

What is the purchase arrangement?

The offer advertises $114 for five bottles totaling 10 mL, marketed as a one-month pack. It says assessment and shipping are included and payment is charged only if prescribed. Automatic refills are described as optional after the initial purchase. Confirm whether recurring supply is selected and how its next charge is determined. [Offer]

The purchase period does not establish how frequently someone should use the preparation. If the clinical plan changes, ask both how to reach the treating professional and how to manage another order. Confirm which pharmacy can answer storage and dispensing questions. Read our first-prescription guide for that distinction.

What can this profile establish?

FDA does not approve compounded drugs. Ingredient studies do not establish this combination's onset, duration, effectiveness or relationship effects. The Viagra label advises against combining it with other PDE5 inhibitors or ED therapies, a question to raise directly when discussing this multi-ingredient preparation. [FDA] [Label]

CoreAge Rx 4Play is our sponsored first placement; links may produce compensation. We have not tried the medicine, enrolled as patients or measured results. A first position is not a clinical recommendation. The service comparison provides other arrangements and questions to bring before deciding on care.

The references

Accessed October 6, 2026. Provider pages document advertised arrangements; medical and regulatory resources supply general context. Neither implies an endorsement.

  1. CoreAge Rx: 4Play product informationSponsored provider; advertised formulation
  2. CoreAge Rx: 4Play offer and refill termsSponsored provider; advertised terms
  3. FDA: Compounding questions and answersRegulatory explanation
  4. Pfizer: Viagra prescribing and patient informationManufacturer labeling; accessed October 6, 2026